Pier 70 Ventures
2801 Alaskan Way, Suite 107, Seattle, WA, 98121, United States
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
DermaSensor | Oct 2025Participated | $16 MSeries B | |
Flyte | Apr 2024Participated | $2 MSeed | |
PrīmSphera | Dec 2023Led | $5 MOther Equity | |
KayoThera | Jul 2023Participated | $5 MSeries A | |
Community | Apr 2023Participated | $25 MOther Equity | |
GeniPhys | Mar 2023Participated | $6 MSeries A | |
DocSpera | Sep 2022Led | $10 MSeries B | |
DermaSensor | Oct 2025Participated | $16 MSeries B | |
Flyte | Apr 2024Participated | $2 MSeed | |
PrīmSphera | Dec 2023Led | $5 MOther Equity | |
KayoThera | Jul 2023Participated | $5 MSeries A | |
Community | Apr 2023Participated | $25 MOther Equity | |
GeniPhys | Mar 2023Participated | $6 MSeries A | |
DocSpera | Sep 2022Led | $10 MSeries B |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 1 |
| Series A | 0 | 2 |
| Series B | 1 | 1 |
| Other Equity | 1 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Sep '22 | 1 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 1 |
| Apr '23 | 1 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 1 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 1 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 1 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 1 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 6 |
| Networks, Cloud & Communication | 2 |
| Hardware & Robotics | 2 |
| AI & Machine Learning | 1 |
| Social & Community Platforms | 1 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 2 |
| $5M-$10M | 2 |
| $10M-$25M | 2 |
| $25M-$50M | 1 |
| $50M-$100M | 0 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 1 of 1 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 7 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Accelerator Life Science Partners | 1 |
| Andy Hill Cancer Research Endowment Fund | 1 |
| Backstage Capital | 1 |
| BioAdvance | 1 |
| Blue Pacific Fund | 1 |
| Boomerang Ventures | 1 |
| Elevate Ventures | 1 |
| GenHenn Capital | 1 |
| GSW Ventures | 1 |
| HubSpot Ventures | 1 |
| Johnson & Johnson Innovation | 1 |
| Kern Venture Group | 1 |
| Life Science Angels | 1 |
| Morgan Stanley | 1 |
| National Institutes of Health | 1 |
| New Jersey Health Foundation | 1 |
| Notre Dame | 1 |
| Salesforce Ventures | 1 |
| Tech Coast Angels | 1 |
| Verizon Ventures | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 2 | 29% |
| Participating | 5 | 71% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 2 | 100% |
Team
Senior Managing Director & General Partner, INpact Fund
Managing Partner